
A small 2024 study reported that people starting a common statin saw their blood sugar markers drift upward, alongside a drop in a gut hormone that Ozempic-type drugs imitate. Researchers think gut bacteria may be part of the story, but most of that evidence comes from mice. Here is what the study found, what much larger trials show about the real size of the effect, and three questions worth asking your doctor. (Based on the insights of Neal K. Shah)
Key Takeaways
- A small 2024 study of 30 people starting atorvastatin found A1C, insulin and insulin resistance rose while the gut hormone GLP-1 fell.
- The proposed explanation is that statins reduce gut bacteria that help make a bile acid (UDCA) supporting GLP-1, but the mechanism comes mostly from mice.
- A 5-person pilot of UDCA looked promising, but with no control group it proves nothing yet; do not self-treat with supplements.
- A 2024 analysis of 19 trials and about 123,000 people found a very small A1C rise (about 0.06 points) alongside around a 22% lower risk of heart attack and stroke.
- Do not stop a statin on your own; ask your doctor about your personal benefit, your A1C and lifestyle changes.
Why This Question Is Worth Asking
Statins are among the most widely used medicines in the world, and roughly one in four US adults over 40 takes one. In large trials they lower LDL cholesterol and reduce heart attacks and strokes. The question here is narrower: could they also nudge blood sugar upward, and if so, how? A 2024 study offers a possible explanation that runs through the gut. It is early research, and it is not a reason to stop a medicine that is protecting your heart.
What The 2024 Study Found
Researchers publishing in Cell Metabolism followed 30 people who were starting atorvastatin 20 mg and 10 comparison participants for 16 weeks. LDL cholesterol dropped within the first week, as expected. By about week 4, however, A1C, the marker that reflects average blood sugar over roughly three months, had crept up and stayed up in the statin group. Fasting insulin and a measure of insulin resistance rose too, and levels of a gut hormone called GLP-1 were lower, by roughly half in the data reported.
It helps to keep the limits in mind. The study was small, it was not blinded, and six of the 30 people starting the statin already had diabetes. It is a clue worth following up, not proof that statins harm blood sugar control in everyone.
What GLP-1 Does
GLP-1 is a hormone released by the gut after you eat. It helps the pancreas release insulin at the right moment, slows how fast the stomach empties and sends fullness signals to the brain. Medicines such as semaglutide, sold as Ozempic, work by copying it. The first drug of this type came from an unlikely source: a protein found in the saliva of the Gila monster, studied by researcher John Eng in the early 1990s. So if a common medicine lowered natural GLP-1 even a little, it would be reasonable to wonder about the effect on blood sugar.
The Proposed Gut Bacteria Link
Statins were first discovered in molds, which make these compounds partly to fend off other microbes. That may matter, because statins appear to reduce certain gut bacteria, including a group called Clostridium. These bacteria help convert a bile acid made in the liver into another one called UDCA (ursodeoxycholic acid), which is thought to support GLP-1 release. In theory, fewer of these bacteria means less UDCA and less GLP-1.
The evidence for that chain comes mostly from mice:
- Bacteria wiped out. When mice had their gut bacteria cleared with antibiotics, statins no longer caused the blood sugar problem.
- Stool transplants. Mice given gut bacteria from people taking statins developed insulin resistance, which was reversed by restoring the bacteria or giving UDCA.
- Diet. Mice fed a high-fiber diet did not develop the problem.
Mice are not people, and none of these results show the same thing happens in your gut.
A Tiny Pilot Points To A Possible Fix
In a pilot of five people, adding UDCA at 500 mg a day for two months was followed by lower A1C and insulin, while LDL stayed the same. With no control group and no blinding, five people can only suggest an idea to test. A randomized trial is reportedly under way. Until it reports, there is no established reason to add UDCA to a statin.
One caution: ursodiol, the medicine form of UDCA, is available by prescription. Supplements with similar-sounding names are not the same product, and they should not be treated as a substitute.
What The Bigger Trials Show
The best check on a small study is a large one. An Oxford-led analysis published in 2024 pooled 19 blinded trials with about 123,000 people followed for more than four years. A1C rose by roughly 0.06 percentage points on a standard statin dose and 0.08 on the highest doses. Over the same period, LDL fell by about 39 mg/dL and the risk of heart attack and stroke fell by around 22 percent. Put in plain numbers, the trials suggested roughly one extra case of diabetes per 1,000 people per year, against about five heart attacks or strokes prevented.
That is a small effect on blood sugar compared with the heart benefit. It matters mostly for people already close to the diabetes line, where a small nudge could tip a number over a threshold.
Why More People May Be Asking This Now
The March 2026 ACC/AHA cholesterol guideline widened the age range for risk assessment to 30 through 79. An analysis reported by the American College of Cardiology estimated that about 88 million US adults are now eligible for a statin under the guideline, including roughly 21.5 million newly eligible, and that 93 percent of adults aged 70 to 79 and 85 percent of those aged 60 to 69 qualify. With so many people considering these medicines, asking good questions matters more than ever.
Who May Want To Pay Closer Attention
People with prediabetes, diabetes, a high A1C, a strong family history of diabetes or features of metabolic syndrome may want to monitor their blood sugar more closely after starting a statin. For most others, the effect is small enough that the heart benefit clearly leads. Either way, it is a conversation to have with the clinician who prescribed the medicine.
Three Questions To Ask Your Doctor
- How much does this pill lower my personal risk? Your benefit depends on your age, blood pressure, smoking status, family history and existing heart disease.
- What is my A1C, and should we recheck it? A baseline number and a follow-up after a few months show whether anything is changing for you.
- Is there a diet or lifestyle change worth making alongside it? Fiber-rich foods, regular activity and a healthy weight support both heart and blood sugar health, whatever the final answer on the gut research turns out to be.
What Not To Do
Do not stop or reduce a prescribed statin on your own because of this research, especially if you have had a heart attack, stroke or stent. Do not buy bile acid supplements to counter a possible effect. If you have noticed new symptoms such as unusual thirst, frequent urination or fatigue after starting a statin, or muscle pain that is severe or unexplained, tell your doctor rather than waiting.
Frequently Asked Questions
Do statins raise blood sugar?
Large trials suggest statins raise A1C slightly, by about 0.06 percentage points at a standard dose. For most people the heart and stroke benefit is far larger, but people already near the diabetes threshold may want their blood sugar monitored.
What is GLP-1 and why does it matter?
GLP-1 is a gut hormone that helps the pancreas release insulin after meals, slows stomach emptying and signals fullness. Ozempic and similar drugs copy it. A 2024 study suggested statin use may lower natural GLP-1 levels, though the study was small.
Should I take UDCA or a bile acid supplement with my statin?
No. A five-person pilot found lower A1C with UDCA, but it had no control group and was not blinded. Ursodiol is a prescription medicine, and supplements with similar names are not the same. A randomized trial is needed first.
Should I stop my statin because of this research?
No. Stopping a statin can raise your risk of heart attack and stroke, particularly if you already have heart disease. Use this research as a reason to ask your doctor about your own risk and blood sugar, not to stop on your own.
Statin Conversation Checklist
- ☐ Keep taking your statin as prescribed unless your doctor says otherwise
- ☐ Ask how much the statin lowers your personal heart attack and stroke risk
- ☐ Ask for your current A1C and whether to recheck it after starting
- ☐ Mention a family history of diabetes or prediabetes to your doctor
- ☐ Ask whether a diet change, such as more fiber, is worth making
- ☐ Skip bile acid or UDCA-type supplements unless prescribed
- ☐ Report unusual thirst, frequent urination or severe muscle pain
- ☐ Bring a list of all medicines and supplements to your next appointment
This article is for general educational purposes and is not medical advice. Do not stop, skip or change a prescribed statin without speaking to your doctor. The gut bacteria findings come mainly from mouse experiments and a very small human study, and they are not yet proven in people. Talk to your doctor about your own heart risk and blood sugar before making any decision.

